Easier injection methods for breast cancer treatment pain
Part of Cancer, Pain, Skin clinical trials.
This study compares two ways of giving Phesgo injections—using a device versus hand injection—to see which causes less pain. You'll receive injections you're already scheduled for, but some will use a special device designed to make the injection smoother and less painful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with HER2-positive breast cancer (a type confirmed by biopsy)
- You've already received at least one Phesgo injection and have at least three more scheduled
- You have not had severe allergic reactions to Phesgo in the past
- You are between 18 and 70 years old
- You have not taken pain medications within 3 days before your injection appointment
- You can move around normally and clearly describe how you're feeling
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests non-drug methods to reduce pain and fear when you get a hormone injection for breast cancer treatment. The goal is to help you feel more comfortable during the shot.
This trial tests two different numbing injections to see which one works better for pain after breast cancer surgery. If you are having a mastectomy, you may be able to join and help find a better way to manage pain.
This study compares giving one pain-relieving injection versus several injections in the back to see which provides better pain control after breast cancer surgery. The goal is to find the best way to reduce pain and help you recover more comfortably.
This study tests a combination pain medicine (Maxigesic) to see how well it controls pain after breast cancer surgery. It may help you need fewer opioids after your operation.
This study tests whether acupuncture (with medication injection at specific points) can reduce joint pain caused by aromatase inhibitors, which are common breast cancer hormone therapies. If you have such pain, you may be able to join.
This study tests whether a new drug called HLX319 works as well as the standard combination drug Phesgo in treating HER2-positive breast cancer before surgery. Both drugs target specific proteins on cancer cells to help shrink tumors and improve outcomes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.